Overview
No overview information available.
Background
No background information available.
Indication
用于使用其他药物疗效不佳的急性心力衰竭的短期静脉治疗。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
Olprinone Hydrochloride Injection | 国药准字H20150028 | 化学药品 | 注射剂 | 2/21/2020 | |
Olprinone Hydrochloride Injection | 国药准字H20233906 | 化学药品 | 注射剂 | 6/30/2023 | |
Olprinone Hydrochloride Injection | 国药准字H20233032 | 化学药品 | 注射剂 | 1/10/2023 | |
Olprinone Hydrochloride Injection | 国药准字H20223294 | 化学药品 | 注射剂 | 5/10/2022 | |
Olprinone Hydrochloride Injection | 国药准字H20234703 | 化学药品 | 注射剂 | 12/26/2023 | |
Olprinone Hydrochloride Injection | 国药准字H20223940 | 化学药品 | 注射剂 | 12/30/2022 | |
Olprinone Hydrochloride Injection | 国药准字H20223671 | 化学药品 | 注射剂 | 2/2/2023 | |
Olprinone Hydrochloride Injection | 国药准字H20223273 | 化学药品 | 注射剂 | 4/29/2022 | |
Olprinone Hydrochloride Injection | 国药准字H20233477 | 化学药品 | 注射剂 | 12/18/2023 | |
Olprinone Hydrochloride Injection | 国药准字H20223247 | 化学药品 | 注射剂 | 4/19/2022 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |